Pollution Drives COPD, Asthma Drug Sales to 3-Year High
Sales of COPD and asthma medications increased at their fastest rate in three years in November as haze engulfed most of the nation and caused respiratory conditions to worsen, especially in the north. The anti-asthma and chronic obstructive pulmonary disease (COPD) category saw its best performance since 2022 in November, up 10% year over year, … Read more